On Friday, Zai Lab Limited ADR (NASDAQ: ZLAB) opened lower -5.74% from the last session, before settling in for the closing price of $17.25. Price fluctuations for ZLAB have ranged from $13.48 to $31.22 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2095.12% over the last five years. Company’s average yearly earnings per share was noted 15.04% at the time writing. With a float of $98.59 million, this company’s outstanding shares have now reached $99.12 million.
The firm has a total of 2175 workers. Let’s measure their productivity.
Zai Lab Limited ADR (ZLAB) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zai Lab Limited ADR is 0.53%, while institutional ownership is 44.15%. The most recent insider transaction that took place on Jul 01 ’24, was worth 180,085. In this transaction Director of this company sold 10,397 shares at a rate of $17.32, taking the stock ownership to the 53,089 shares. Before that another transaction happened on Jul 01 ’24, when Company’s Chairperson & CEO sold 7,013 for $17.48, making the entire transaction worth $122,573. This insider now owns 1,081,910 shares in total.
Zai Lab Limited ADR (ZLAB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.04% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Check out the current performance indicators for Zai Lab Limited ADR (ZLAB). In the past quarter, the stock posted a quick ratio of 3.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.07, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -1.81 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Analysing the last 5-days average volume posted by the [Zai Lab Limited ADR, ZLAB], we can find that recorded value of 0.83 million was better than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 14.24%. Additionally, its Average True Range was 1.15.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 31.34%, which indicates a significant increase from 5.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.23% in the past 14 days, which was lower than the 62.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.35, while its 200-day Moving Average is $20.97. Now, the first resistance to watch is $17.08. This is followed by the second major resistance level at $17.89. The third major resistance level sits at $18.43. If the price goes on to break the first support level at $15.73, it is likely to go to the next support level at $15.19. Should the price break the second support level, the third support level stands at $14.38.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
There are currently 99,609K shares outstanding in the company with a market cap of 1.61 billion. Presently, the company’s annual sales total 266,720 K according to its annual income of -334,620 K. Last quarter, the company’s sales amounted to 87,150 K and its income totaled -53,470 K.
